Search Results for: KEAP1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
GLRX5 glutaredoxin 5
  • Mitochondrial iron-sulfur cluster biogenesis
  • Erythropoietic porphyria (EP), including: Erythropoietic protoporphyria (EPP); Congenital erythropoietic porphyria (CEP); Gunther Disease; X-linked erythropoietic protoporphyria (XLEPP)
  • Sideroblastic anemia, including: Pyridoxine-refractory autosomal recessive sideroblastic anemia (PRARSA); X-linked sideroblastic anemia (XLSA); X-linked sideroblastic anemia with ataxia (ASAT)
WHRN whirlin
  • Usher syndrome (US)
  • Deafness, autosomal recessive
AMER1 APC membrane recruitment protein 1
  • Degradation of beta-catenin by the destruction complex
  • Beta-catenin phosphorylation cascade
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Signaling by GSK3beta mutants
  • S33 mutants of beta-catenin aren't phosphorylated
  • S37 mutants of beta-catenin aren't phosphorylated
  • S45 mutants of beta-catenin aren't phosphorylated
  • T41 mutants of beta-catenin aren't phosphorylated
  • APC truncation mutants have impaired AXIN binding
  • AXIN missense mutants destabilize the destruction complex
  • Truncations of AMER1 destabilize the destruction complex
  • Osteopathia striata with cranial sclerosis
CAT catalase
  • Detoxification of Reactive Oxygen Species
  • Neutrophil degranulation
  • Peroxisomal protein import
  • Peroxisomal protein import
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Fomepizole
  • Cannabidiol
  • Medical Cannabis
  • Nabiximols
  • Acatalasia, including: Acatalasemia; Takahara's disease; Hypocatalasemia
ICAM1 intercellular adhesion molecule 1
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Integrin cell surface interactions
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Interferon gamma signaling
  • Natalizumab
  • Hyaluronic acid
  • Nafamostat
  • Allograft rejection
IFIH1 interferon induced with helicase C domain 1
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • TRAF6 mediated NF-kB activation
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • Negative regulators of DDX58/IFIH1 signaling
  • Negative regulators of DDX58/IFIH1 signaling
  • Type I diabetes mellitus
PALB2 partner and localizer of BRCA2
  • HDR through Homologous Recombination (HRR)
  • Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
  • Resolution of D-loop Structures through Holliday Junction Intermediates
  • Homologous DNA Pairing and Strand Exchange
  • Fanconi anemia
SNRPN small nuclear ribonucleoprotein polypeptide N
  • mRNA Splicing - Major Pathway
  • Prader-Willi and Angelman syndromes, including: Angelman syndrome (AS); Prader-Willi syndrome (PWS)
SQSTM1 sequestosome 1
  • NRIF signals cell death from the nucleus
  • p75NTR recruits signalling complexes
  • NF-kB is activated and signals survival
  • PINK1-PRKN Mediated Mitophagy
  • Interleukin-1 signaling
  • Pexophagy
  • Paget's disease of bone and related disorders, including: ; Paget's disease of bone (PDB); Familial expansile osteolysis (FEO); Early-onset Paget's disease of bone (PDB2); Expansile skeletal hyperphosphatasia (ESH); Juvenile Paget's disease (JPD)
AK4 adenylate kinase 4
  • Interconversion of nucleotide di- and triphosphates
ANKS1A ankyrin repeat and sterile alpha motif domain containing 1A
ATG5 autophagy related 5
  • Macroautophagy
  • Macroautophagy
  • PINK1-PRKN Mediated Mitophagy
  • Receptor Mediated Mitophagy
  • Negative regulators of DDX58/IFIH1 signaling
BAD BCL2 associated agonist of cell death
  • Activation of BAD and translocation to mitochondria
  • Activation of BAD and translocation to mitochondria
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • NRAGE signals death through JNK
  • AKT phosphorylates targets in the cytosol
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Navitoclax
BPTF bromodomain PHD finger transcription factor
C2orf68 chromosome 2 open reading frame 68
CARD10 caspase recruitment domain family member 10
CCNB1IP1 cyclin B1 interacting protein 1
CDK6 cyclin dependent kinase 6
  • Oxidative Stress Induced Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Cyclin D associated events in G1
  • Regulation of RUNX1 Expression and Activity
  • Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
  • Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
  • Alvocidib
  • (2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol
  • Fisetin
  • Palbociclib
  • Ribociclib
  • Abemaciclib
CLU clusterin
  • Platelet degranulation
  • Terminal pathway of complement
  • Antimicrobial peptides
  • Regulation of Complement cascade
  • Zinc
  • Copper
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
CPEB2 cytoplasmic polyadenylation element binding protein 2

Page 2 out of 5 pages